Seqirus’ Received Health Canada approval of first cell-based seasonal influenza vaccine
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Dec. 11, 2019, Seqirus announced that its cell-based quadrivalent influenza vaccine (QIVc) had received approval from Health…
On Oct. 24, 2019, Penn Medicine researchers received $9.7 million grant from the NIH to study traumatic brain…
On Oct. 7, 2019, Penn Medicine announced it had developed gene therapy to treat Duchenne muscular dystrophy (DMD)…
On Oct. 4, 2019, Penn Medicine announced they had received $22 Million from National Institutes of Health’s (NIH)…
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
On Nov. 18, 2015, the estate of Glenn Korff gifted $5 million to the Fred & Pamela Buffett…
On Dec. 12, 2014, Sanofi Pasteur announced the U.S. Food and Drug Administration (FDA) had approved the supplemental…
In Feb. 2013, the Center for Personalized Diagnostics (CPD) was established at UPenn for researching genomic and therapeutic…
In 2012, the Basser Center for BRCA was established at Penn Medicine’s Abramson Cancer Center to establish a…
On Oct. 17, 2007, the Food and Drug Administration (FDA) approved quadrivalent meningococcal conjugate vaccine (MCV4) (Menactra®, Sanofi…
On Oct. 22, 1999, the Advisory Committee on Immunization Practices (ACIP), after a review of scientific data from…
On Oct. 15, 1999, Wyeth-Lederle Vaccines announced that it was withdrawing the Rotashield vaccine from the market and…
On Oct. 2, 1996, the Food and Drug Administration (FDA) licensed a combined Hib conjugate and hepatitis B…
In 1990, the University of Pittsburgh Cancer Institute received National Cancer Institute (NCI) Comprehensive designation. The University of…
In 1981, Dr. Alexa Canady became the first African American woman in the U.S. to become a neurosurgeon,…
Om Mar. 28, 1979,the Three Mile Island Unit 2 (TMI-2) reactor, near Middletown, Pa., partially melted down resulting…
On Nov. 21, 1977, the U.S. Food and Drug Administration (FDA) licensed the first pneumococcal vaccine containing 14…
In 1972, the Pennsylvania Association for Retarded Children v. Commonwealth of Pennsylvania and Mills v. Board of Education…
In 1972, The Wistar Institute was designated the first National Cancer Institute (NCI) Cancer Center in basic research…
In 1968, the University of Pennsylvania Institute for Environmental Medicine was established in recognition of the increasing need…
In 1967, the American Chemical Society awarded the Priestley Medal to Ralph Connor “to recognize distinguished services to…
In 1967, H. Keffer Hartline, born in Bloomsburg, Pennsylvania and graduate of Layfayette College in Easton, PA (B.Sc….
In 1962, the American Chemical Society awarded the Priestley Medal Joel H. Hildebrand “to recognize distinguished services to…
On Jan. 27, 1956, Dr. Jonas Salk, developer of the Polio vaccine released in 1955, received a special…
In February 1954, first-, second- and third-grade students from five suburban schools were the first to be inoculated…
In 1954, Dr. Jonas Salk and associates develop a potentially safe injectable vaccine against polio given to nearly…
In 1951, Lewis L. Coriell whose history in polio research began during his residency at Children’s Hospital of…
In 1951, Dr. Jonas Salk and his team began using Dr. John F. Enders’ methods to grow poliovirus,…
In 1949, Dr. Jonas Salk, with grants from the National Foundation for Infantile Paralysis, the Pitt team and…
In 1948, the American Chemical Society awarded the Priestley Medal to Edward R. Weidlein “to recognize distinguished services…